Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

NCT03393962 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

BIOLOGICAL: OC-EIEs

Sponsor

Shenzhen Geno-Immune Medical Institute